Penumbra, Inc. (PEN) Social Stream
PENUMBRA INC (PEN) Price Targets From Analysts
Use the tables below to see what analysts covering PENUMBRA INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 6 | $350 | $204 | $303.666 | $258.15 | 17.63% |
| 2021-11-05 | 7 | $350 | $204 | $302.428 | $258.15 | 17.15% |
| 2022-02-17 | 6 | $350 | $308 | $323.6 | $258.15 | 25.35% |
| 2022-02-23 | 5 | $308 | $300 | $302.666 | $258.15 | 17.24% |
| 2022-04-29 | 5 | $308 | $250 | $289.5 | $258.15 | 12.14% |
| 2022-05-04 | 6 | $308 | $250 | $289.5 | $258.15 | 12.14% |
| 2022-05-05 | 6 | $308 | $240 | $261.6 | $258.15 | 1.34% |
| 2022-05-17 | 5 | $308 | $220 | $254.666 | $258.15 | -1.35% |
| 2022-08-05 | 7 | $265 | $163 | $211.571 | $258.15 | -18.04% |
| 2022-08-08 | 8 | $265 | $163 | $200 | $258.15 | -22.53% |
| 2022-09-13 | 8 | $265 | $163 | $210.444 | $258.15 | -18.48% |
| 2022-09-19 | 8 | $265 | $163 | $213.333 | $258.15 | -17.36% |
| 2022-10-05 | 9 | $265 | $163 | $213 | $258.15 | -17.49% |
| 2022-10-12 | 10 | $265 | $163 | $214.7 | $258.15 | -16.83% |
| 2022-10-28 | 10 | $265 | $175 | $218.6 | $258.15 | -15.32% |
| 2022-10-31 | 10 | $265 | $189 | $223.1 | $258.15 | -13.58% |
| 2022-11-04 | 10 | $265 | $189 | $223.1 | $258.15 | -13.58% |
| 2022-11-07 | 11 | $244 | $167 | $202.9 | $258.15 | -21.4% |
| 2022-11-14 | 11 | $235 | $167 | $206.8 | $258.15 | -19.89% |
| 2022-12-05 | 11 | $240 | $167 | $210.4 | $258.15 | -18.5% |
| 2022-12-12 | 11 | $270 | $167 | $219.2 | $258.15 | -15.09% |
| 2022-12-13 | 11 | $270 | $185 | $227.9 | $258.15 | -11.72% |
| 2023-01-03 | 11 | $270 | $185 | $230.6 | $258.15 | -10.67% |
| 2023-01-05 | 11 | $270 | $185 | $235.4 | $258.15 | -8.81% |
| 2023-01-30 | 12 | $275 | $185 | $241.727 | $258.15 | -6.36% |
| 2023-01-31 | 12 | $284 | $185 | $244.363 | $258.15 | -5.34% |
| 2023-02-01 | 12 | $285 | $185 | $247.181 | $258.15 | -4.25% |
| 2023-02-24 | 12 | $300 | $195 | $267.454 | $258.15 | 3.6% |
| 2023-03-17 | 12 | $303 | $215 | $280 | $258.15 | 8.46% |
| 2023-03-28 | 12 | $320 | $215 | $283.272 | $258.15 | 9.73% |
| 2023-05-02 | 12 | $320 | $215 | $286.09 | $258.15 | 10.82% |
| 2023-05-03 | 12 | $325 | $300 | $310.545 | $258.15 | 20.3% |
| 2023-05-18 | 12 | $350 | $300 | $313.272 | $258.15 | 21.35% |
| 2023-05-24 | 12 | $350 | $300 | $316.454 | $258.15 | 22.59% |
| 2023-06-05 | 12 | $350 | $300 | $317.909 | $258.15 | 23.15% |
| 2023-06-27 | 12 | $367 | $300 | $321.727 | $258.15 | 24.63% |
| 2023-07-10 | 12 | $390 | $300 | $329.636 | $258.15 | 27.69% |
| 2023-07-12 | 12 | $390 | $300 | $333.818 | $258.15 | 29.31% |
| 2023-07-17 | 13 | $390 | $300 | $335.909 | $258.15 | 30.12% |
| 2023-08-02 | 13 | $390 | $300 | $340.833 | $258.15 | 32.03% |
| 2023-09-06 | 13 | $390 | $300 | $337.75 | $258.15 | 30.83% |
| 2023-09-08 | 14 | $390 | $300 | $337.75 | $258.15 | 30.83% |
| 2023-10-04 | 14 | $390 | $265 | $332.153 | $258.15 | 28.67% |
| 2023-10-13 | 14 | $375 | $265 | $326.769 | $258.15 | 26.58% |
| 2023-11-03 | 14 | $375 | $240 | $301.769 | $258.15 | 16.9% |
| 2023-12-12 | 14 | $375 | $207 | $287.538 | $258.15 | 11.38% |
| 2023-12-20 | 14 | $375 | $207 | $289.461 | $258.15 | 12.13% |
| 2023-12-22 | 14 | $375 | $207 | $292.846 | $258.15 | 13.44% |
| 2023-12-29 | 14 | $375 | $207 | $295.153 | $258.15 | 14.33% |
The Trend in the Analyst Price Target
PEN's average price target has moved down $23.54 over the prior 74 days.
PEN reports an average of 27.42% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-01 | 12 | 285 | 185 | 247.181 | 257.30 | -3.93% |
| 2023-08-18 | 13 | 390 | 300 | 337.750 | 251.22 | 34.44% |
| 2023-09-20 | 14 | 390 | 265 | 332.153 | 262.43 | 26.57% |
| 2023-10-09 | 14 | 375 | 265 | 326.769 | 223.07 | 46.49% |
| 2023-10-10 | 14 | 375 | 265 | 326.769 | 232.90 | 40.3% |
PEN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.36 | 11 | 1 | 2 | 0 | 0 | 14 |
The Trend in the Broker Recommendations
Over the past 26 weeks, PEN's average broker recommendation rating worsened by 0.11.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PEN as an investment opportunity.
- PEN has a greater average analyst price target than 5576.79% of all US stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, PENUMBRA INC's upside potential (average analyst target price relative to current price) is greater than 1149.12% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, PENUMBRA INC's variance in analysts' estimates is lower than -1619.98% of them.
- In terms of how PENUMBRA INC fares relative to Healthcare stocks, note that its number of analysts covering the stock is higher than 3745.17% of that group.
In the Medical Equipment industry, NVCR, PODD, and DXCM are the three stocks most similar to PENUMBRA INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding PEN using the data that counts. Try POWR Ratings for free.